Aflac Incorporated

Horace Mann Educators reported second-quarter revenues of $443.5 million, up 7.7% year on year, making it the best performer among the 12 life insurance stocks tracked. The company's results were in line with analysts' expectations and included a beat of EPS estimates. Brighthouse Financial was the weakest, with revenues of $2.10 billion, down 2.4% year on year and missing expectations by 2%. Equitable Holdings reported revenues of $3.73 billion, down 1.9% year on year, while Aflac reported revenues of $4.22 billion, down 6.9% year on year. As a group, the 12 life insurance stocks missed consensus revenue estimates by 8.2%.

Aflac reported second-quarter revenue of $4.22 billion, a 6.9% year-on-year decline that was in line with analyst estimates of $4.23 billion, while adjusted EPS of $1.75 also matched expectations of $1.76. Management attributed the drop largely to tough comparisons in Japan following last year's launch of the Miraito cancer insurance product, though new offerings like Tsumitasu and Anshin Palette produced solid growth. In the U.S., sales growth was modest but supported by strength in group voluntary products and network dental and vision, with disciplined expense management helping to preserve margins. During the earnings call, analysts questioned the sustainability of asset repositioning efforts, the appetite for larger M&A deals, sequential declines in Japanese medical sales, the impact of inflation and higher rates on policy lapses, and the capital freed by expanding Japanese reinsurance. Aflac currently trades at $120.60, down from $126.66 just before the earnings.

Aflac reported second-quarter revenue of $4.12 billion, missing analyst estimates of $4.23 billion and marking a 9.2% year-on-year decline. Adjusted earnings per share came in at $1.75, in line with the consensus estimate of $1.76. Book value per share rose 18.7% year on year to $60.35, beating expectations of $55.23. Chairman and CEO Daniel P. Amos highlighted solid earnings and strategic execution, including new product initiatives in Japan and a focus on supplemental health products in the U.S. The stock fell 1.4% to $124.92 following the release.

Aflac shares may be trading about 10% above fair value as analysts project declining revenue and thinner profit margins. The stock closed at $129.55, while the most followed narrative pegs fair value at $117.71, implying the stock is overvalued. Analysts expect Aflac's revenue to shrink by 1.1% annually over the next three years, with profit margins contracting from 25.6% to 20.5%. However, a separate discounted cash flow model from Simply Wall St estimates fair value at $168.47, suggesting the stock is undervalued. Aflac's heavy reliance on Japan, declining net earned premiums, higher technology costs, and softer U.S. sales growth could challenge the fair value story.

StockStory identified Aflac, Columbia Financial, and Washington Trust Bancorp as growth stocks facing an uphill battle due to weak fundamentals. Aflac saw net premiums earned decline 6.2% annually over five years, a projected 4.8% drop in book value per share, and a high debt-to-equity ratio of 1.9 times. Columbia Financial posted flat net interest income over five years, a low net interest margin of 2.1%, and a 3.8% annual decline in earnings per share. Washington Trust Bancorp recorded 4.3% annual net interest income growth, a net interest margin of 2.3%, and a 9.6% annual drop in earnings per share despite flat revenue.

Aflac Life Insurance announced on the 13th that the number of individuals affected by a personal data leak due to unauthorized access has risen to about 4.4 million, an increase of 20,000 from the initial disclosure. The investigation revealed that the unauthorized access first occurred on June 10, and the number of people whose insurance premium transfer account information was leaked has been revised from about 230,000 to about 220,000. In response to a reporting order from the Financial Services Agency, the company plans to submit a report summarizing the investigation results and measures to prevent recurrence by the end of July. It is prioritizing sending apology letters to customers whose account information was leaked and is coordinating with relevant financial institutions in its response.

Aflac's stock presents conflicting valuation signals following a cybersecurity breach at its Japanese subsidiary. The Excess Returns model estimates an intrinsic value of about $169.90 per share, roughly 30.3% above the current price, suggesting the stock is undervalued. However, the shares trade at a price-to-earnings ratio of about 13.0 times, above the fair-value framework's estimate of 10.0 times, indicating overvaluation. The recent cyber incident at Aflac Life Insurance Japan introduces operational and reputational risk that may partly explain the discount to intrinsic value. Overall, the stock scores 3 out of 6 on value tests, leaving its next move dependent on whether the market favors the Excess Returns upside or the cautious earnings multiple signal.

The first-quarter life insurance earnings season saw mixed results, with the 12 tracked stocks collectively beating revenue estimates by 3.1% while share prices rose 7.3% on average. Aflac reported revenues of $4.24 billion, down 1.8% year on year and missing analyst expectations by 1.7%, though it beat book value per share estimates. Primerica was the best performer with revenues of $872.3 million, up 8.6% year on year and beating estimates by 1.9%, while Brighthouse Financial was the weakest, posting revenues of $2.10 billion, down 2.7% and missing estimates by 4.8%. Jackson Financial delivered the largest revenue beat at 49.8% but saw the slowest revenue growth, and Equitable Holdings had the weakest performance against analyst estimates with a 7.3% revenue miss.